Early parenteral lipids and growth velocity in extremely-low-birth-weight infants

Céline Julie Fischer1, Delphine Maucort-Boulch2, Christine Murielle Essomo Megnier-Mbo3

  • 1Service de Réanimation Néonatale et Néonatologie, Hôpital Femme Mère Enfants, Hospices Civils de Lyon, Bron, France; Service de Néonatologie, Département Médico-Chirurgical de Pédiatrie, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Switzerland.

Insights

Early parenteral lipids significantly improve weight gain and head circumference growth in extremely-low-birth-weight infants. This suggests early lipid administration enhances postnatal growth and nutritional support for preterm neonates.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Growth and Development

Background:

  • Postnatal growth in extremely-low-birth-weight (ELBW) infants is critical.
  • The role of early parenteral lipids in optimizing growth velocity remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of early parenteral lipid administration on the growth velocity of ELBW infants.
  • To assess the association between cumulative parenteral lipid intake and growth parameters.

Main Methods:

  • Retrospective cohort study of 121 ELBW infants.
  • Analysis of associations between parenteral lipid intake (cumulative and delayed introduction) and growth velocities (weight, head circumference, length) up to 28 days and 36 weeks corrected age.
  • Uni- and multivariate linear regression analyses were employed.

Main Results:

  • Positive associations were observed between cumulative early parenteral lipid intake and weight gain (up to 28 days and 36 weeks corrected age) and head circumference growth (up to 28 days).
  • Delayed introduction of parenteral lipids correlated negatively with weight gain up to 28 days.
  • Multivariate analyses confirmed the independence of these associations from other key neonatal factors.

Conclusions:

  • Early administration of parenteral lipids in the first week is positively associated with improved weight gain in ELBW infants.
  • Parenteral lipids are crucial for enhancing early nutritional support and promoting optimal growth in preterm neonates.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...